# Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer

> **NCT00003726** · PHASE1,PHASE2 · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** lepirudin

## Key facts

- **NCT ID:** NCT00003726
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-11
- **Primary completion:** 2001-07
- **Final completion:** 2001-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study funding was dropped.
- **Last updated:** 2016-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003726, "Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT00003726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*